Lab to £30m+ in Revenue and a $310m Exit | Eric Mayes

Eric Mayes, Chief Executive Officer, Endomag

Join Chris Reichhelm in conversation with Eric Mayes, PhD, CEO of Endomag, as they dive into the rare and full lab-to-market journey of a Medtech startup. Eric discusses how he led Endomag from a university spinout to achieving product market fit, profitability, and ultimately a $310 million acquisition by Hologic. Eric’s insights into navigating regulatory landscapes, securing funding, and creating a global clinical impact make this a must-listen for anyone in Deep Tech or Medtech. Discover what it takes to bring groundbreaking innovations from the lab all the way to market.

To learn more about Lab-to-Market Leadership, view our presentation: ‘The Lab-to-Market Journey – a Blueprint.’